Literature DB >> 6449677

Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.

S A Montgomery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6449677     DOI： 10.1016/0028-3908(80)90199-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  3 in total

1.  Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.

Authors:  R Muscat; M Papp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  A double-blind trial of mianserin and nomifensine in depressed outpatients.

Authors:  W Hamouz; R Van Dorth; R M Pinder; S M Stulemeijer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 3.  Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R C Heel; P A Morley; R N Brogden; A A Carmine; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.